Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

Liranaftate (CAS 88678-31-3)

0.0(0)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
(6-Methoxy-2-pyridinyl)-methylcarbamothioic Acid; O-(5,6,7,8-Tetrahydro-2-naphthyl) N-(6-Methoxy-2-pyridyl)-N-methylthiocarbamate
Application:
Liranaftate is a squalene epoxidase inhibitor
CAS Number:
88678-31-3
Purity:
≥99%
Molecular Weight:
328.43
Molecular Formula:
C18H20N2O2S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Liranaftate is a synthetic chemical compound categorized under the thiocarbamate class, renowned for its antifungal properties, specifically targeting a broad spectrum of dermatophytes and yeast-like fungi. The mechanism of action of liranaftate involves the inhibition of squalene epoxidase, an enzyme crucial for ergosterol synthesis, which is an essential component of the fungal cell membrane. By inhibiting this enzyme, liranaftate disrupts the cell membrane′s integrity, leading to the accumulation of toxic intermediates such as squalene, thus hindering fungal cell growth and proliferation. In research contexts, liranaftate has been extensively utilized to study the biochemical pathways involved in fungal ergosterol biosynthesis. This research has been instrumental in understanding the adaptive mechanisms fungi employ to resist antifungal agents and in exploring the molecular basis of enzyme inhibition by thiocarbamates. Furthermore, the effectiveness of liranaftate in inhibiting specific fungal enzymes has provided insights into potential targets for new antifungal agents, contributing significantly to the fields of microbiology and biochemistry. Through such studies, liranaftate not only aids in advancing our knowledge of fungal physiology and pathology but also enhances our understanding of the complex interactions within fungal cells that can be manipulated for various non-therapeutic applications in science.


Liranaftate (CAS 88678-31-3) References

  1. [Fungicidal activity of liranaftate against Trichophyton rubrum].  |  Oku, Y., et al. 2002. Nihon Ishinkin Gakkai Zasshi. 43: 181-7. PMID: 12145634
  2. [Anti-fungal drug liranaftate suppresses fungal element-promoted production of IL-8 in normal human keratinocytes].  |  Kobayashi, M., et al. 2008. Nihon Ishinkin Gakkai Zasshi. 49: 319-22. PMID: 19001760
  3. In vitro antifungal activities of luliconazole, a new topical imidazole.  |  Koga, H., et al. 2009. Med Mycol. 47: 640-7. PMID: 19115136
  4. [Suppression of experimental inflammation by anti-fungal agent liranaftate in mice].  |  Maruyama, N., et al. 2010. Nihon Ishinkin Gakkai Zasshi. 51: 7-11. PMID: 20185866
  5. [Suppression of experimental footpad inflammatory reaction by anti-fungal agent liranaftate in mice].  |  Maruyama, N., et al. 2012. Med Mycol J. 53: 129-33. PMID: 22728596
  6. [In vitro Antifungal Activity of Luliconazole against Trichophyton spp].  |  Maeda, J., et al. 2016. Med Mycol J. 57: J1-6. PMID: 26936346
  7. Liranaftate loaded Xanthan gum based hydrogel for topical delivery: Physical properties and ex-vivo permeability.  |  Mishra, B., et al. 2018. Int J Biol Macromol. 107: 1717-1723. PMID: 29020654
  8. Itching in a trichophytin contact dermatitis mouse model and the antipruritic effect of antifungal agents.  |  Nakamura, T., et al. 2019. Clin Exp Dermatol. 44: 381-389. PMID: 30187507
  9. Anti-inflammatory effect of lanoconazole on 12-O-tetradecanoylphorbol-13-acetate- and 2,4,6-trinitrophenyl chloride-induced skin inflammation in mice.  |  Nakamura, A., et al. 2020. Mycoses. 63: 189-196. PMID: 31724251
  10. Inferences of carboplatin response-related signature by integrating multiomics data in ovarian serous cystadenocarcinoma.  |  Yan, JQ., et al. 2022. Exp Biol Med (Maywood). 247: 910-920. PMID: 35285286

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Liranaftate, 10 mg

sc-207828
10 mg
$190.00